Title | Author(s) | Issue date | ???itemlist.??? |
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Carboplatin and Paclitaxel versus Cisplatin, Paclitaxel and Doxorubicin for first-line chemotherapy of Advanced Ovarian Cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Bamias, A.; Grimani, I.; Rizos, S.; Kalofonos, H. P.; Skarlos, D. V.; Economopoulos, T.; Kosmidis, P. A.; Stathopoulos, G. P.; Briasoulis, E.; Pectasides, D.; Samantas, E.; Timotheadou, E.; Papadimitriou, C.; Papanikolaou, A.; Onyenadum, A.; Papakostas, P.; Bafaloukos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group | Skarlos, D. V.; Dimopoulos, A. M.; Kosmidis, P.; Papakostas, P.; Pavlidis, N.; Bacoyiannis, C.; Kiamouris, C.; Klouvas, G.; Gogas, H.; Fountzilas, G.; Samantas, E. | 24-Nov-2015 | - |
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study | Fountzilas, G.; Nicolaides, C.; Aravantinos, G.; Skarlos, D.; Kosmidis, P.; Papakostas, P.; Stathopoulos, G. P.; Kontostolis, E.; Bafaloukos, D.; Pavlidis, N. | 24-Nov-2015 | - |
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Papadimitriou, C.; Dafni, U.; Bafaloukos, D.; Skarlos, D.; Moulopoulos, L. A.; Razis, E.; Kalofonos, H. P.; Aravantinos, G.; Briassoulis, E.; Papakostas, P.; Abela, K.; Gogas, E.; Kosmidis, P.; Pavlidis, N.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study | Koutras, A. K.; Kalogeras, K. T.; Dimopoulos, M. A.; Wirtz, R. M.; Dafni, U.; Briasoulis, E.; Pectasides, D.; Gogas, H.; Christodoulou, C.; Aravantinos, G.; Zografos, G.; Timotheadou, E.; Papakostas, P.; Linardou, H.; Razis, E.; Economopoulos, T.; Kalofonos, H. P.; Fountzilas, G. | 24-Nov-2015 | - |
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy | Malamou-Mitsi, V.; Gogas, H.; Dafni, U.; Bourli, A.; Fillipidis, T.; Sotiropoulou, M.; Vlachodimitropoulos, D.; Papadopoulos, S.; Tzaida, O.; Kafiri, G.; Kyriakou, V.; Markaki, S.; Papaspyrou, I.; Karagianni, E.; Pavlakis, K.; Toliou, T.; Scopa, C.; Papakostas, P.; Bafaloukos, D.; Christodoulou, C.; Fountzilas, G. | 24-Nov-2015 | - |
Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group | Skarlos, D. V.; Bai, M.; Goussia, A.; Samantas, E.; Galani, E.; Tsavdaridis, D.; Karina, M.; Papakostas, P.; Konstantara, A.; Fountzilas, G. | 24-Nov-2015 | - |
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial | Pentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G. | 24-Nov-2015 | - |
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer | Aravantinos, G.; Dimopoulos, M. A.; Kosmidis, P.; Bafaloukos, D.; Papadimitriou, C.; Kiamouris, C.; Pavlidis, N.; Sikiotis, K.; Papakostas, P.; Skarlos, D. V. | 24-Nov-2015 | - |
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma - A Hellenic Cooperative Oncology Group Phase II Study | Fountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Karanikiotis, C.; Bai, M.; Misailidou, D.; Samantas, E.; Athanassiou, E.; Papamichael, D.; Tsekeris, P.; Catodritis, N.; Nicolaou, A.; Plataniotis, G.; Makatsoris, T.; Papakostas, P.; Zamboglou, N.; Daniilidis, J. | 24-Nov-2015 | - |
Induction Chemotherapy with Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy in Patients with Inoperable Non-nasopharyngeal Carcinoma of the Head and Neck | Fountzilas, G.; Bamias, A.; Kalogera-Fountzila, A.; Karayannopoulou, G.; Bobos, M.; Athanassiou, E.; Kalogeras, K. T.; Tolis, C.; Tsekeris, P.; Papakostas, P.; Vamvouka, C.; Zaramboukas, T.; Kosmidis, P.; Zamboglou, N.; Misailidou, D. | 24-Nov-2015 | - |
Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer | Kalofonos, H. P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K. N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. | 24-Nov-2015 | - |
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study | Briasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N. | 24-Nov-2015 | - |
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group | Koutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P. | 24-Nov-2015 | - |
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data | Mauri, D.; Pentheroudakis, G.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Efstathiou, E.; Kalofonos, H. P.; Syrigos, K.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Fountzilas, G.; Pavlidis, N. | 24-Nov-2015 | - |
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation | Fountzilas, G.; Kourea, H. P.; Bobos, M.; Televantou, D.; Kotoula, V.; Papadimitriou, C.; Papazisis, K. T.; Timotheadou, E.; Efstratiou, I.; Koutras, A.; Pentheroudakis, G.; Christodoulou, C.; Aravantinos, G.; Miliaras, D.; Petraki, K.; Papandreou, C. N.; Papakostas, P.; Bafaloukos, D.; Repana, D.; Razis, E.; Pectasides, D.; Dimopoulos, A. M. | 24-Nov-2015 | - |
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Kalofonos, H. P.; Dafni, U.; Papadimitriou, C.; Bafaloukos, D.; Papakostas, P.; Kalogera-Fountzila, A.; Gogas, H.; Aravantinos, G.; Moulopoulos, L. A.; Economopoulos, T.; Pectasides, D.; Maniadakis, N.; Siafaka, V.; Briasoulis, E.; Christodoulou, C.; Tsavdaridis, D.; Makrantonakis, P.; Razis, E.; Kosmidis, P.; Skarlos, D.; Dimopoulos, M. A. | 24-Nov-2015 | - |
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Papakostas, P.; Dafni, U.; Makatsoris, T.; Karina, M.; Kalogera-Fountzila, A.; Maniadakis, N.; Aravantinos, G.; Syrigos, K.; Bamias, A.; Christodoulou, C.; Economopoulos, T.; Kalofonos, H.; Nikolaou, A.; Angouridakis, N.; Stathopoulos, G.; Bafaloukos, D.; Pavlidis, N.; Daniilidis, J. | 24-Nov-2015 | - |
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study | Aravantinos, G.; Fountzilas, G.; Kosmidis, P.; Dimopoulos, M. A.; Stathopoulos, G. P.; Pavlidis, N.; Bafaloukos, D.; Papadimitriou, C.; Karpathios, S.; Georgoulias, V.; Papakostas, P.; Kalofonos, H. P.; Grimani, E.; Skarlos, D. V. | 24-Nov-2015 | - |